創傷治療デバイス市場- 世界の産業規模、シェア、動向、機会、予測、セグメント、創傷タイプ別、製品別、エンドユーザー別、地域別、競合、2020年～2030年

創傷治療デバイスの世界市場規模は2024年に48億8,000万米ドルで、2030年までのCAGRは5.01%で2030年には65億6,000万米ドルに達すると予測されています。

世界の創傷治療デバイス市場は、慢性創傷の増加、高齢者人口の増加、医療技術の進歩などを背景に大きな成長を遂げています。創傷治療デバイスには、陰圧創傷治療（NPWT）システム、酸素・高気圧酸素装置、電気刺激装置、圧迫緩和装置など、創傷の効果的な治癒と管理を促進するよう設計されたさまざまな製品が含まれます。中でもNPWTシステムは、肉芽組織の形成を促進し細菌負荷を軽減することで創傷治癒を促進する効果があるため、大きな人気を集めています。

糖尿病性足潰瘍や褥瘡などの慢性創傷の原因となる糖尿病や肥満の増加が、市場拡大の主な要因となっています。世界の外科手術の急増により、術後の創傷を管理するための高度な創傷ケア製品に対する需要が高まっています。デジタルモニタリングを統合したスマート創傷ケア機器の開発などの技術革新は、リアルタイムのデータと個別化された治療オプションを提供することで、市場の成長をさらに促進する見通しです。しかし、先進的な創傷治療デバイスの高価格や厳しい規制要件が市場成長の課題となる可能性があります。このような課題にもかかわらず、在宅ヘルスケアサービスの採用が増加しており、より効率的で費用対効果の高い創傷ケアソリューションの研究が進められていることから、創傷治療デバイス市場は今後数年間プラス基調を維持すると予想されます。

市場促進要因

慢性創傷の有病率の上昇

医療技術の進歩

老人人口の増加

主な市場課題

先進医療コストの高さ

厳しい規制要件

限られた償還政策

主な市場動向

非侵襲的治療への需要の高まり

急性創傷および外傷における用途の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別（慢性創傷、急性創傷）
  • 製品別（陰圧閉鎖療法（NPWT）、酸素および高圧酸素装置、電気刺激デバイス、圧力緩和デバイス、その他）
  • エンドユーザー別（病院、専門クリニック、在宅ヘルスケア、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの創傷治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 創傷タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• 3M Company
• Cardinal Health, Inc.
• Convatec Group plc
• Smith & Nephew Plc
• Paul Hartmann AG
• Sechrist Industries, Inc.
• Molnlycke Health Care AB
• Medela AG

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Wound Therapy Devices Market was valued at USD 4.88 Billion in 2024 and is expected to reach USD 6.56 Billion by 2030 with a CAGR of 5.01% through 2030. The global wound therapy devices market has been experiencing significant growth, driven by increasing incidences of chronic wounds, rising geriatric population, and advancements in medical technology. Wound therapy devices encompass a range of products designed to promote effective wound healing and management, including negative pressure wound therapy (NPWT) systems, oxygen and hyperbaric oxygen equipment, electric stimulation devices, and pressure relief devices. Among these, NPWT systems have gained substantial popularity due to their efficacy in enhancing wound healing by promoting granulation tissue formation and reducing bacterial load.

The growing prevalence of diabetes and obesity, which contribute to the occurrence of chronic wounds such as diabetic foot ulcers and pressure ulcers, is a key factor fueling the market's expansion. The surge in surgical procedures worldwide has led to an increased demand for advanced wound care products to manage post-operative wounds. Technological innovations, such as the development of smart wound care devices that integrate digital monitoring, are poised to further enhance market growth by providing real-time data and personalized treatment options. However, the high cost of advanced wound therapy devices and stringent regulatory requirements may pose challenges to market growth. Despite these challenges, the increasing adoption of home healthcare services and the ongoing research into more efficient and cost-effective wound care solutions are expected to sustain the positive trajectory of the wound therapy devices market in the coming years.

Key Market Drivers

Rising Prevalence of Chronic Wounds

The global wound therapy devices market is significantly driven by the rising prevalence of chronic wounds, which include diabetic foot ulcers, pressure ulcers, and venous leg ulcers. These chronic wounds are becoming increasingly common due to a combination of factors such as the global rise in diabetes and obesity rates, an aging population, and an increase in immobility among patients. Diabetic foot ulcers are a major concern as diabetes continues to affect millions worldwide. Diabetic foot ulcers, a frequent and severe complication of diabetes, pose a significant risk of infection and amputation if not managed properly. The need for effective wound care solutions to manage and treat these ulcers is a key driver of the wound therapy devices market. Advanced wound care technologies, such as Negative Pressure Wound Therapy (NPWT), have proven to be highly effective in promoting healing and preventing complications.

Pressure ulcers, also known as bedsores, are another critical area of concern, especially among the elderly and immobile patients. These ulcers develop due to prolonged pressure on the skin and underlying tissues, often occurring in bedridden patients or those with limited mobility. The growing geriatric population, coupled with increased hospitalizations and long-term care requirements, has led to a higher incidence of pressure ulcers. Specialized wound therapy devices, such as pressure relief mattresses and NPWT systems, are essential in managing and treating these wounds.

Venous leg ulcers, resulting from poor blood circulation in the lower extremities, are also contributing to the rising demand for advanced wound care devices. The increasing prevalence of chronic venous insufficiency and related conditions necessitates the use of effective wound therapy solutions to promote healing and enhance patient outcomes.

Advancements in Medical Technology

One of the most transformative advancements in wound care technology is Negative Pressure Wound Therapy (NPWT). NPWT systems utilize sub-atmospheric pressure to promote wound healing by drawing out exudate, reducing edema, and enhancing tissue granulation. This technology is particularly effective for managing complex and chronic wounds such as diabetic foot ulcers, pressure ulcers, and surgical wounds. The ability of NPWT to accelerate the healing process and reduce the risk of infection has made it a cornerstone in advanced wound care, significantly boosting its adoption across healthcare settings. In January 2022, Smith & Nephew received clearance from the U.S. Food and Drug Administration (FDA) for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy Systems. These advanced devices are now approved for use on closed surgical incisions to help reduce the risk of superficial and deep surgical site infections (SSIs) in high-risk patients, as well as to prevent post-operative seroma and dehiscence. This approval highlights Smith & Nephew's commitment to enhancing wound care solutions and improving patient outcomes.

The development of smart wound care devices represents another leap forward in medical technology. These devices incorporate digital sensors and wireless connectivity to monitor wound conditions in real time. By providing continuous data on parameters such as moisture levels, temperature, and exudate volume, smart wound care devices enable healthcare providers to make informed decisions and tailor treatments to individual patients' needs. This personalized approach not only enhances the efficacy of wound care but also improves patient compliance and satisfaction. In April 2022, Sky Medical Technology Ltd. announced that its Geko device would be available on the Government of India e-Marketplace (GeM) procurement portal. This development allows government hospitals across India to access the Geko device, an innovative wound therapy solution designed to prevent life-threatening blood clots and manage complications related to swelling in patients following orthopedic surgeries and those with chronic wounds. The device's availability aims to improve patient care and treatment outcomes in healthcare facilities throughout the country.

Innovations in bioactive dressings and skin substitutes are also contributing to the growth of the wound therapy devices market. These products are designed to create an optimal healing environment by promoting cell proliferation and tissue regeneration. Bioactive dressings, which may contain antimicrobial agents, growth factors, or extracellular matrix components, help accelerate wound closure and reduce the risk of infection. Skin substitutes, including both synthetic and biological materials, offer effective solutions for severe wounds that require advanced healing support.

Increasing Geriatric Population

The growing geriatric population is a crucial factor driving the expansion of the global wound therapy devices market. As life expectancy increases, the number of elderly individuals worldwide is rising, leading to a higher prevalence of age-related health issues, including chronic wounds. This demographic shift is significantly influencing the demand for advanced wound care solutions. Elderly individuals are more prone to developing chronic wounds, such as pressure ulcers, venous leg ulcers, and diabetic foot ulcers, due to several physiological changes associated with aging. Reduced skin elasticity, slower cell regeneration, and a weakened immune system make the elderly more susceptible to wounds and infections. Comorbidities common in older adults, such as diabetes, cardiovascular diseases, and impaired mobility, further increase the risk of chronic wound development.

The management of chronic wounds in the elderly requires advanced wound care devices to ensure effective healing and prevent complications. Negative Pressure Wound Therapy (NPWT) systems, electric stimulation devices, and bioactive dressings are particularly beneficial for this age group. These technologies promote faster wound healing, reduce infection rates, and improve overall patient outcomes. As the elderly population continues to grow, the demand for such advanced wound care solutions is expected to rise correspondingly.

The increasing geriatric population also drives the demand for long-term care and home healthcare services. Many elderly patients prefer receiving care in the comfort of their homes or long-term care facilities rather than in hospitals. Portable and user-friendly wound therapy devices cater to this need by providing continuous and effective wound care outside traditional healthcare settings. This trend towards home-based care not only enhances patient quality of life but also alleviates the burden on healthcare systems.

Key Market Challenges

High Cost of Advanced Wound Therapy Devices

One of the most significant challenges hindering the global wound therapy devices market is the high cost associated with advanced wound care technologies. Devices such as Negative Pressure Wound Therapy (NPWT) systems, electric stimulation devices, and bioactive dressings often come with substantial price tags. The initial purchase cost, coupled with maintenance and consumable expenses, can be prohibitive for many healthcare providers and patients. In low- and middle-income countries, where healthcare budgets are constrained, the adoption of these advanced technologies is particularly challenging. Even in more affluent regions, budgetary limitations within healthcare institutions can restrict the widespread implementation of costly wound therapy devices. This financial barrier can lead to disparities in access to optimal wound care, resulting in suboptimal patient outcomes and prolonged healing times for those who cannot afford these advanced solutions.

Stringent Regulatory Requirements

Stringent regulatory requirements represent another major challenge in the wound therapy devices market. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), impose rigorous standards to ensure the safety and efficacy of medical devices. While these regulations are crucial for patient safety, they can also create significant hurdles for manufacturers. The process of obtaining regulatory approval is often lengthy, complex, and expensive, requiring extensive clinical trials and documentation. Smaller companies and startups may struggle to meet these stringent requirements due to limited resources, slowing down innovation and market entry. Differences in regulatory standards across regions complicate the approval process for companies seeking to market their products globally, leading to delays and increased costs.

Limited Reimbursement Policies

Limited reimbursement policies pose a significant challenge to the growth of the wound therapy devices market. In many healthcare systems, reimbursement for advanced wound care products and devices is either insufficient or non-existent. This lack of coverage can deter healthcare providers from adopting these technologies, as the financial burden may fall on patients. Even in countries with established reimbursement frameworks, the policies often do not fully cover the costs associated with advanced wound care devices, leading to out-of-pocket expenses for patients. This can result in decreased accessibility to effective wound care, particularly for economically disadvantaged populations. The complexity and variability of reimbursement policies across different regions further complicate the market, as manufacturers must navigate a complex landscape to ensure their products are covered and reimbursed adequately.

Key Market Trends

Increasing Demand for Non-Invasive Treatments

The increasing demand for non-invasive wound therapy treatments reflects a paradigm shift in healthcare towards more patient-centric and efficient approaches to wound management. Patients, particularly those with chronic wounds, are seeking alternatives to invasive procedures that often entail prolonged hospital stays, discomfort, and increased risk of complications. Non-invasive modalities such as Negative Pressure Wound Therapy (NPWT) have emerged as game-changers in wound care, offering a gentle yet effective way to promote healing while allowing patients to maintain their daily activities. In November 2022, Medela LLC entered into a partnership with MedPro Healthcare Sales Solutions to expand access to Medela's wound therapy systems. This collaboration strengthens Medela's nationwide presence by providing comprehensive coverage through 60 skilled account managers, supporting acute, post-acute, and government healthcare channels.

NPWT, one of the most widely adopted non-invasive treatments, applies controlled negative pressure to the wound site, promoting blood flow, reducing edema, and facilitating the removal of exudate and infectious materials. This therapy not only accelerates the healing process but also minimizes pain and discomfort, making it a preferred choice for patients and healthcare providers alike. Similarly, electrical stimulation therapy utilizes low-voltage electrical currents to stimulate wound healing at the cellular level, enhancing tissue regeneration and reducing inflammation. Oxygen therapy, another non-invasive modality, delivers concentrated oxygen to the wound bed, creating an optimal environment for healing and combating infection.

The advantages of non-invasive treatments extend beyond clinical efficacy to encompass patient satisfaction and healthcare economics. By reducing the need for invasive surgical procedures, non-invasive modalities mitigate the risk of surgical site infections, hospital-acquired complications, and lengthy hospital stays, resulting in significant cost savings for healthcare systems. The ability to administer these treatments in outpatient settings enhances patient convenience and autonomy, promoting adherence to treatment regimens and improving overall outcomes. In response to the growing demand for non-invasive wound therapy solutions, manufacturers are investing in research and development to enhance the efficacy, usability, and accessibility of their devices. This includes the integration of advanced features such as wireless connectivity, smart sensors, and user-friendly interfaces, which streamline treatment delivery and monitoring while ensuring optimal patient comfort and safety.

Expanding Applications in Acute and Traumatic Wounds

In acute care settings, wound therapy devices are playing an increasingly pivotal role in expediting the healing process and improving patient outcomes. Negative pressure wound therapy (NPWT) systems, for instance, are proving to be invaluable in managing acute wounds by promoting granulation tissue formation, reducing edema, and enhancing blood flow to the wound bed. These systems create a controlled environment conducive to healing, thereby minimizing the risk of infection and accelerating tissue regeneration. Hydrogel dressings, another essential component of acute wound care, provide a moist healing environment that facilitates autolytic debridement and promotes epithelialization. Their ability to maintain moisture balance and absorb excess exudate makes them particularly effective in managing surgical wounds and partial-thickness burns, where maintaining a moist wound environment is paramount for optimal healing.

Advanced wound dressings, including foams, films, and hydrocolloids, are also gaining prominence in acute care settings due to their versatility and effectiveness in managing various wound types. These dressings provide a barrier against external contaminants, promote tissue regeneration, and facilitate the removal of necrotic tissue, thereby expediting the healing process and reducing the risk of complications. In December 2022, Firstkind Ltd, a subsidiary of Sky Medical Technology, and Al Raya Medical Equipment signed an exclusive distribution agreement for the Geko device in Qatar.

The expanding applications of wound therapy devices in acute and traumatic wounds underscore their versatility and potential for market growth. As healthcare providers increasingly recognize the importance of early and effective wound management in preventing complications and improving patient outcomes, the demand for these devices is expected to continue rising. Ongoing advancements in technology and materials science are fueling the development of innovative wound care solutions tailored to meet the unique needs of acute and traumatic wound patients, further driving market expansion.

Segmental Insights

Product Insights

In 2024, the Negative Pressure Wound Therapy (NPWT) segment emerged as the dominant segment in the global wound therapy devices market. NPWT systems have demonstrated exceptional efficacy in promoting wound healing, particularly for complex and chronic wounds such as diabetic foot ulcers, pressure ulcers, and surgical wounds. By applying sub-atmospheric pressure to the wound site, NPWT helps reduce edema, remove exudate, and enhance tissue granulation, significantly accelerating the healing process.

The versatility of NPWT systems makes them suitable for a wide range of wound types and care settings. From acute surgical wounds to chronic ulcers, NPWT devices provide a reliable solution that can be tailored to various clinical needs. This broad applicability contributes to their widespread use and market dominance. Recent technological advancements have further bolstered the appeal of NPWT devices. Innovations such as portable and disposable NPWT systems have made the therapy more accessible and convenient for both healthcare providers and patients, facilitating use in home care and outpatient settings. These advancements have expanded the reach of NPWT, making it a preferred choice for wound management.

End User Insights

In 2024, the hospitals segment emerged as the dominant end-user segment in the global wound therapy devices market. wounds that require sophisticated treatment protocols. They are equipped with the necessary infrastructure, such as advanced wound care units and state-of-the-art medical equipment, to provide effective and intensive wound management.

Hospitals have better access to advanced wound therapy devices, such as Negative Pressure Wound Therapy (NPWT) systems, electric stimulation devices, and hyperbaric oxygen equipment. These facilities can afford the high costs associated with these advanced technologies, ensuring they can provide the best possible care for wound management. Hospitals employ a wide range of skilled healthcare professionals, including wound care specialists, surgeons, and nursing staff who are trained in advanced wound care techniques. The presence of multidisciplinary teams ensures that patients receive holistic and expert care, which is crucial for the treatment of complex wounds.

Regional Insights

In 2024, North America emerged as the dominant region in the global wound therapy devices market, holding the largest market share. North America boasts advanced healthcare infrastructure, including state-of-the-art hospitals, specialty wound care centers, and research institutions. The region's robust healthcare system enables widespread adoption of advanced wound therapy devices and facilitates innovation in wound care technologies.

The United States and Canada consistently rank among the countries with the highest healthcare expenditure globally. The substantial investment in healthcare resources and technologies allows for the extensive use of advanced wound therapy devices in clinical practice. Healthcare providers in North America have the financial resources to procure cutting-edge wound care products and provide optimal patient care. North America is a hub for technological innovation in healthcare, with numerous companies dedicated to developing and manufacturing advanced wound therapy devices. The region's strong emphasis on research and development drives continuous advancements in wound care technologies, ensuring that healthcare providers have access to the latest and most effective treatment options.

Key Market Players

• 3M Company
• Cardinal Health, Inc.
• Convatec Group plc
• Smith & Nephew Plc
• Paul Hartmann AG
• Sechrist Industries, Inc.
• Molnlycke Health Care AB
• Medela AG

Report Scope:

In this report, the Global Wound Therapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Therapy Devices Market, By Wound Type:

• Chronic Wounds
• Acute Wounds

Wound Therapy Devices Market, By Product:

• Negative Pressure Wound Therapy (NPWT)
• Oxygen and Hyperbaric Oxygen Equipment
• Electric Stimulation Devices
• Pressure Relief Devices
• Others

Wound Therapy Devices Market, By End User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Wound Therapy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wound Therapy Devices Market.

Available Customizations:

Global Wound Therapy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Wound Therapy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Wound Type (Chronic Wounds, Acute Wounds)
  • 5.2.2. By Product (Negative Pressure Wound Therapy (NPWT), Oxygen and Hyperbaric Oxygen Equipment, Electric Stimulation Devices, Pressure Relief Devices, Others)
  • 5.2.3. By End-User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Wound Therapy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Wound Type
  • 6.2.2. By Product
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wound Therapy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Wound Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-User
  • 6.3.2. Mexico Wound Therapy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Wound Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-User
  • 6.3.3. Canada Wound Therapy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Wound Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-User

7. Europe Wound Therapy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Wound Type
  • 7.2.2. By Product
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Wound Therapy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Wound Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-User
  • 7.3.2. Germany Wound Therapy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Wound Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Wound Therapy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Wound Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Wound Therapy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Wound Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Wound Therapy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Wound Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Wound Therapy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Wound Type
  • 8.2.2. By Product
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Wound Therapy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Wound Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Wound Therapy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Wound Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-User
  • 8.3.3. South Korea Wound Therapy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Wound Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-User
  • 8.3.4. Japan Wound Therapy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Wound Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Wound Therapy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Wound Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-User

9. South America Wound Therapy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Wound Type
  • 9.2.2. By Product
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Wound Therapy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Wound Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Wound Therapy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Wound Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Wound Therapy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Wound Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Wound Therapy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Wound Type
  • 10.2.2. By Product
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Wound Therapy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Wound Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Wound Therapy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Wound Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Wound Therapy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Wound Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. 3M Company
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Cardinal Health, Inc.
• 14.3. Convatec Group plc
• 14.4. Smith & Nephew Plc
• 14.5. Paul Hartmann AG
• 14.6. Sechrist Industries, Inc.
• 14.7. Molnlycke Health Care AB
• 14.8. Medela AG

15. Strategic Recommendations

16. About Us & Disclaimer